Medtronic (MDT) Tops Q1 EPS by 2c; Reiterates Outlook

Go back to Medtronic (MDT) Tops Q1 EPS by 2c; Reiterates Outlook

Jefferies Raises Price Target on Medtronic (MDT) to $100 Following 1Q Report

August 26, 2016 10:42 AM EDT

Jefferies reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $100.00 (from $93.00), following the company's 1Q earnings report. EPS was reported $0.02 above estimates. FX was only $7mn v. the $25- $75mn guided to and the company missed consensus by about... More

Oppenheimer Raises Price Target on Medtronic (MDT) to $94 Following EPS Beat

August 26, 2016 9:44 AM EDT

Oppenheimer reiterated an Outperform rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $94.00 (from $90.00), following the company's 1Q earnings report. MDT reported a $0.02 EPS beat, driven by a slightly lower interest expense and tax rate.

Analyst Steven Lichtman commented,... More

UBS Reiterates Buy on Medtronic (MDT) Following 1Q Report

August 26, 2016 8:55 AM EDT

UBS reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $96.00 (from $92.00), following the company's 1Q earnings report. Management reiterated F17 guidance of 5-6% top-line adjusted CC growth and EPS guidance of $4.60-4.70.

Analyst Matt Miksic commented, "Management delivered on its F1Q17 guidance of 5.0 5.5% adjusted... More